<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01514383</url>
  </required_header>
  <id_info>
    <org_study_id>R11-009</org_study_id>
    <nct_id>NCT01514383</nct_id>
  </id_info>
  <brief_title>Octylseal Surgical Adhesive in General Surgery</brief_title>
  <official_title>Evaluation of Octylseal as a Topical Surgical Skin Incision Adhesive in General Surgery: A Case Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medline Industries</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medline Industries</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate how surgical adhesive is used.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this Case Series Study, clinician experience and subject outcomes will be recorded in the
      use of a topical skin adhesive (Octylseal) on the closure of skin incisions from General
      surgical procedures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound Length Closure</measure>
    <time_frame>During Surgery</time_frame>
    <description>Primary incision wound length treatment in adult and pediatric general surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With a Score of &quot;0&quot; (No Hurt) on the Pain Rating Scale</measure>
    <time_frame>At Surgery</time_frame>
    <description>Pain was assessed using the Wong-Baker FACESâ„¢ Pain Rating Scale, with 0 =No Hurt to 10=Hurts Worst</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Wounds</condition>
  <arm_group>
    <arm_group_label>Surgical Adhesive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The surgical adhesive (cyanoacrylate) will be used once to close the topical skin surgical incision created during surgical procedures.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cyanoacrylate (Octylseal )</intervention_name>
    <description>surgical adhesive</description>
    <arm_group_label>Surgical Adhesive</arm_group_label>
    <other_name>cyanoacrylate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Candidate for use of a topical surgical skin adhesive

        Exclusion Criteria:

          -  Subjects with know sensitivity to topical surgical tissue adhesive products or
             degrading products (cyanoacrylates or formaldehyde)

          -  Subjects with a history of keloid formation, hypotension, insulin dependent diabetes
             mellitus, blood/clotting disorders, peripheral vascular diseases or hypertrophy
             history

          -  Subjects who present with a contraindications for product usage as per labeling

          -  A wound with evidence of active infection or gangrene or wounds of decubitus etiology

          -  Mucosal surfaces or across mucocutaneous junctions or skin that might be exposed to
             bodily fluids or with dense natural hair

          -  Subjects with known hypersensitivity to cyanoacrylate or formaldehyde
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ed Drower, MS</last_name>
    <role>Study Director</role>
    <affiliation>Medline Industries</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jersey City Medical Center</name>
      <address>
        <city>Jersey City</city>
        <state>New Jersey</state>
        <zip>07302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wyckoff Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>11237</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>January 12, 2012</study_first_submitted>
  <study_first_submitted_qc>January 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2012</study_first_posted>
  <results_first_submitted>August 28, 2017</results_first_submitted>
  <results_first_submitted_qc>May 6, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 7, 2019</results_first_posted>
  <last_update_submitted>May 6, 2019</last_update_submitted>
  <last_update_submitted_qc>May 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>wounds</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Surgical Adhesive</title>
          <description>Cyanoacrylate (Octylseal ): surgical adhesive</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Octylseal</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Adult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47.5" spread="17.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pediatric</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11.3" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Wound Length Closure</title>
        <description>Primary incision wound length treatment in adult and pediatric general surgery</description>
        <time_frame>During Surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Wound Length Closure of Paticipants Treated With Octylseal</title>
          </group>
        </group_list>
        <measure>
          <title>Wound Length Closure</title>
          <description>Primary incision wound length treatment in adult and pediatric general surgery</description>
          <units>milimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.97" spread="24.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pediatric</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.00" spread="10.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With a Score of &quot;0&quot; (No Hurt) on the Pain Rating Scale</title>
        <description>Pain was assessed using the Wong-Baker FACESâ„¢ Pain Rating Scale, with 0 =No Hurt to 10=Hurts Worst</description>
        <time_frame>At Surgery</time_frame>
        <population>All 34 participants</population>
        <group_list>
          <group group_id="O1">
            <title>No Pain Reported</title>
            <description>Wong-Baker FACESâ„¢ Pain Rating Scale Pain Rating Scale from 0-10, with 0 =No Hurt to 10=Hurts Worst</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With a Score of &quot;0&quot; (No Hurt) on the Pain Rating Scale</title>
          <description>Pain was assessed using the Wong-Baker FACESâ„¢ Pain Rating Scale, with 0 =No Hurt to 10=Hurts Worst</description>
          <population>All 34 participants</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>14 days</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Octylseal</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <description>Of 74 incisions/lacerations treated in 34 patients, there was one (1) documented report of a possible incisional infection (1.4%). The complication was deemed not related to octylsealâ„¢.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ed Drower, Clinical Project Director</name_or_title>
      <organization>Medline Industries, Inc</organization>
      <phone>847-643-3874</phone>
      <email>edrower@medline.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

